Abcam, ab240977, Anti-DRIP130 antibody [EPR17418] - BSA and Azide free

Size: 100µg / 1mg
Rabbit Recombinant Monoclonal DRIP130 antibody. Carrier free. Suitable for WB, ICC/IF, IHC-P and reacts with Mouse, Rat, Human samples. Cited in 1 publication.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EPR17418,
Isotype:IgG,
Carrier free:Yes,
Reacts with:Mouse, Rat, Human,
Applications:IHC-P, WB, ICC/IFSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Product details:
ab240977 is the carrier-free version of
ab200351
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our
conjugation kits
for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar
Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar
is a trademark of Fluidigm Canada Inc.

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.2 - 7.4Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C, Storage information-Do Not Freeze

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
DRIP130 also known as MED23 is a component of the Mediator complex. It plays a significant role as a transcriptional co-activator for RNA polymerase II transcription. DRIP130 has a molecular mass of approximately 130 kDa. Expression of DRIP130 occurs in various tissues more notably in the liver and heart indicating its widespread biological roles in the body.
Biological function summary
DRIP130 integrates signals from activators and repressors to facilitate transcription regulation. It is a part of the larger Mediator complex which is essential for conveying instructions from transcription factors to RNA polymerase II. By acting at promoters DRIP130 helps modulate gene expression impacting processes like cell growth and differentiation. Its function within this multi-subunit complex emphasizes its importance in cellular communication and transcriptional regulation.
Pathways
DRIP130 contributes to the MAPK/ERK signaling pathway and the Wnt signaling pathway. Within these pathways it interacts with proteins such as MAPK and β-catenin to influence cell cycle progression and cellular responses. These pathways are critical for controlling growth and maintaining cellular functions indicating DRIP130's vital role in pathway integration and cellular homeostasis.
DRIP130 has connections to cancer and neurological disorders. Alterations in DRIP130 expression or function can lead to aberrant cell proliferation contributing to cancer development. Moreover DRIP130's interaction with proteins like β-catenin in the Wnt pathway may influence neurological conditions by affecting neural cell signaling or development. Understanding these links provides insight into potential therapeutic targets for managing such disorders.